课题基金 / 基金详情

USC ADRC Diversity Supplement - Guzman

USC ADRC Diversity Supplement - Guzman
南加州大学 ADRC 多样性补充 - 古兹曼
批准号:
10457217
负责人:
HELENA Chang CHUI
金额:
$5.72万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-02-28
关键词:
AgeAlzheimer&aposs DiseaseAlzheimer’s disease biomarkerAmyloidAnimalsAxonBasic ScienceBiologicalBiological MarkersBiologyBlood VesselsBrain PathologyCaregiversCatchment AreaCellsCessation of lifeCharacteristicsClinicalClinical ResearchCohort StudiesComplexConflict (Psychology)Confounding Factors (Epidemiology)DataData SetDatabasesDementiaDevelopmentDiagnosisDiseaseEnrollmentEvaluationFosteringGene ExpressionGeneticGenetic TranscriptionGoalsGossypiumHealth SciencesHeterogeneityHippocampus (Brain)HistologicHistologyHumanImageImage AnalysisIndividualLate Onset Alzheimer DiseaseLatinxLatinx populationMagnetic Resonance ImagingMentorsMetabolicMethodsMicrogliaMicroscopicMinorityMinority GroupsModelingMolecularMolecular GeneticsMutationNeurofibrillary TanglesNeuronsNeuropil ThreadsParticipantPathogenesisPathologicPlayPositron-Emission TomographyPostdoctoral FellowPrevalenceProcessRNARNA analysisResearchResearch PersonnelResourcesRisk FactorsRoleSenile PlaquesSlideSpastic ParaparesisSpecificityStandardizationSubgroupSystemTechniquesTemporal LobeTherapeutic InterventionTimeTissuesTranslational ResearchUnderrepresented MinorityVascular DiseasesWoolWorkaging brainapolipoprotein E-4autosomal dominant Alzheimer&aposs diseasebrain researchcell typecohortdata managementdiagnostic biomarkerdigital imagingdoctoral studenteducation researchgamma secretaseneuroinflammationneuron lossneuropathologyneurotoxicneurovascular unitnovel diagnosticsoutreachpersonalized medicinepre-clinicalpresenilin-1preservationrecruitresearch studyspecific biomarkersstandard measuretau Proteinstherapeutically effectivetranscriptomicsvascular contributionswhole slide imaging

项目摘要

项目成果

HELENA Chang CHUI的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract The 3 overarching goals of the USC Alzheimer Disease Research Center (ADRC) are to: 1) Elucidate vascular contributions to Alzheimer disease (AD), 2) catalyze basic, clinical, and translational research in AD at USC, and 3) contribute expertise in vascular disease, biomarkers, and imaging to national collaborative initiatives. The ADRC is led by 3 multiple PD/PIs: Chui, Zlokovic, and Toga and comprised of 6 required cores, the required Research Education Component (REC), and 1 optional imaging core. The Administration Core (Chui, Zlokovic, Toga) provides administrative and scientific oversight across USC ADRC, including fostering development projects and supporting ADRC-affiliated studies. The Clinical Core (Schneider, Ringman, Chui) performs standardized evaluations and diagnoses using the NACC Uniform Data Set (UDS), enrolls and follows participants in our 2 primary ADRC cohorts: Vascular Cohort Study (VCS) and Brain Research Study (BRS). The Data Management and Statistical Core (Toga and Chen) oversees the NACC UDS database, provides study- and core-specific databases and curates our large imaging data sets as a local and national resource. The Neuropathology Core (Miller and Hawes) performs standardized neuropathological examinations, stores and distributes biological tissues to research investigators. The Outreach, Recruitment, and Engagement Core (Aranda) works closely with the Clinical Core to recruit and retain the primary ADRC cohort, focusing on under- represented minority groups (especially Latinx), and the development of a participant-caregiver dyad resource database. The Biomarker Core (Zlokovic) uses state of the art methods to determine cell-and system-specific biomarkers related to the neurovascular unit, as well as to measure standard AD biomarkers. The Imaging Core (Toga and Pa) provides high field (3T and 7T) MR imaging, as well as amyloid/tau PET scans. The Research Education Component (Yassine) is dedicated to mentoring post-doctoral students committed to the study of minority issues in Alzheimer disease and related disorders. The USC Health Science Campus is located near high Latinx catchment areas. Treatable vascular-metabolic risk factors (VMRF) are particularly prevalent among the Latinx population and dovetail with the research focus of the USC ADRC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Asian Cohort for Alzheimer's Disease (ACAD)
  • 批准号:
    10555689
  • 项目类别:
  • 资助金额:
    $832.6万
  • 财政年份:
    2023
  • 负责人:
    HELENA Chang CHUI
  • 依托单位:
Quantitative cerebral blood vessel imaging biomarkers for AD and VCID
  • 批准号:
    10214060
  • 项目类别:
  • 资助金额:
    $21.48万
  • 财政年份:
    2021
  • 负责人:
    HELENA Chang CHUI
  • 依托单位:
Quantitative cerebral blood vessel imaging biomarkers for AD and VCID
Administrative Core
  • 批准号:
    9922627
  • 项目类别:
  • 资助金额:
    $37.46万
  • 财政年份:
    2020
  • 负责人:
    HELENA Chang CHUI
  • 依托单位: